Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.
Funding Blaize, a US-based developer of edge artificial intelligence technology, completed a $71m series D round yesterday co-led by Franklin Templeton and Temasek that included automotive component manufacturer Denso. Formerly known as ThinCI, the company had raised an undisclosed amount from Denso, peer Magna International and unnamed individuals in 2016, before Denso and its NSitexe…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.